Sleep plays a crucial role in the restoration and recovery of the human body. Humans, as mammals, experience a single main sleep episode—nighttime sleep—which is not uniform throughout the night. It consists of five primary phases:

  • During the first stage, slow theta rhythms appear in the brain, with amplitudes exceeding alpha rhythms typical of wakefulness. Muscle activity, pulse, and body temperature decrease, creating a state often described as light drowsiness.
  • The second stage, known as light sleep, follows. Theta rhythms continue, accompanied by “sleep spindles” or sigma rhythms that help disconnect consciousness.
  • The third stage features delta waves, marking deep sleep. If delta waves exceed 50%, this corresponds to the fourth stage.
  • The fifth and final stage is rapid eye movement (REM) sleep, or paradoxical sleep, during which hormone production intensifies and dreaming typically occurs.

Each sleep cycle lasts about 90 minutes on average. Delta sleep is considered the most restorative and important for recovery.

In 1977, a unique peptide called DSIP (Delta Sleep-Inducing Peptide) was isolated from the brains of rats during deep sleep phases. It earned its name for its ability to induce sleep in rabbits.

Additional Physiological Effects of DSIP Peptide

DSIP influences several important physiological processes, including:

  • Modulation of corticotropin levels, which regulate adrenal cortex hormones such as cortisol, cortisone, and corticosterone.
  • Reduction of somatostatin production, which normally inhibits natural growth hormone secretion.
  • Normalization of blood pressure.
  • Reduction of overall stress levels.
  • Alteration of pain perception.

Medical research holds high hopes for DSIP, with ongoing studies investigating its potential applications in cancer treatment, depression, and age-related degenerative conditions.

Structure of the DSIP Peptide

DSIP is a nonapeptide consisting of nine amino acids: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE). It is also known in scientific circles as emidelide, DSIP nonapeptide, or deltaran.

How Does DSIP Affect Sleep?

For a long time, the connection between DSIP and sleep regulation remained unclear. However, numerous studies have confirmed that DSIP normalizes sleep without causing strong sedative effects. This is especially evident in chronic insomnia cases, where DSIP improved sleep efficiency by increasing total sleep time by 59% compared to placebo and reducing the time needed to fall asleep.

DSIP and Chronic Pain Management

Long-term use of NSAIDs, opioids, and other painkillers often leads to serious side effects. DSIP offers promising alternatives with its dose-dependent, prolonged analgesic effects, even in patients resistant to other treatments. Importantly, DSIP does not cause dependency or withdrawal symptoms despite acting on opioid receptors.

Studies on patients undergoing alcohol and opioid withdrawal showed that 97% of alcohol-dependent and 87% of opioid-dependent patients experienced full or significant pain relief using DSIP.

DSIP’s Role in Metabolism

Animal studies have shown that DSIP restores normal oxidative phosphorylation even under hypoxic conditions, reducing harmful byproducts caused by impaired oxygen metabolism during stress. This suggests potential uses for DSIP in treating strokes and heart attacks.

DSIP is also considered a powerful antioxidant, preserving mitochondrial function and preventing free radical formation.

Can DSIP Improve Depression Symptoms?

Research indicates that DSIP helps maintain stable levels of monoamine oxidase type A (MAO-A) and serotonin, both critical for mental health regulation. Reduced DSIP levels were detected in cerebrospinal fluid of patients with depression.

However, clinical trials testing DSIP as a depression treatment are still pending.

Potential of DSIP in Cancer Prevention

Preclinical studies on mice reveal that lifelong DSIP administration reduces cancer incidence by 2.6 times and decreases chromosomal defects by over 20%. Ongoing research also explores DSIP’s ability to prevent central nervous system damage caused by chemotherapy, showing promising initial results.

DSIP and Muscle Mass

While the exact site of DSIP synthesis and its physiological function are still under investigation, its inhibition of somatostatin supports hypertrophic growth of skeletal muscles. Scientists believe DSIP’s full spectrum of effects is broader and warrants further study.